Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients.

about

Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients.

Item

http://www.wikidata.org/entity/Q36007020

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Emerging agents for the preven ...... enia in adult cancer patients.

@ast

Emerging agents for the preven ...... enia in adult cancer patients.

@en

type

Item

label

Emerging agents for the preven ...... enia in adult cancer patients.

@ast

Emerging agents for the preven ...... enia in adult cancer patients.

@en

prefLabel

Emerging agents for the preven ...... enia in adult cancer patients.

@ast

Emerging agents for the preven ...... enia in adult cancer patients.

@en

P1476

Emerging agents for the preven ...... enia in adult cancer patients.

@en

P2093

Alexios Matikas

http://www.w3.org/2001/XMLSchema#string

Athanasios Kotsakis

http://www.w3.org/2001/XMLSchema#string

Vassilis Georgoulias

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

Myelotoxicity from chemotherapy.

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

P304

157-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14728214.2016.1184646

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27139914

http://www.w3.org/2001/XMLSchema#string